Caveolae are a major membrane domain common to most cells. One of the defining features of this domain is the protein caveolin. The exact function of caveolin, however, is not clear. One possible function is to attract adapter molecules to caveolae in a manner similar to how clathrin attracts molecules to coated pits. Here, we characterize a candidate adapter molecule called SRBC. SRBC binds PKCd and is a member of the STICK (substrates that interact with C-kinase) superfamily of PKC-binding proteins. We also show it co-immunoprecipitates with caveolin-1. A leucine zipper in SRBC is essential for both co-precipitation with caveolin and localization to caveolae. SRBC remains associated with caveolin when caveolae bud to form vesicles (cavicles) that travel on microtubules to different regions of the cell. In the absence of SRBC, intracellular cavicle traffic is markedly impaired. We conclude that SRBC (sdr-related gene product that binds to c-kinase) and two other family members [PTRF (Pol I and transcription release factor) and SDPR] function as caveolin adapter molecules that regulate caveolae function.
Introduction
Caveolae are the most abundant membrane domain on the cell surface devoted to endocytosis. They can occupy 18-40% of the plasma membrane surface (Chang et al, 1994) and engage in at least three different types of dynamic activities (Mundy et al, 2002; White and Anderson, 2005) . Type 1 caveolae are able to pinch off the membrane to form endocytic vesicles called cavicles (Mundy et al, 2002) that can carry cargo such as SV40 virus to specialized endosomes called caveosomes (Pelkmans et al, 2001) . Cavicles can also travel to the recycling endosome region of the cell (Mundy et al, 2002) . Cavicle movement to these sites is microtubule dependent. Type 2 caveolae, which are the most abundant type, superficially appear not to be dynamic (Thomsen et al, 2002) . Recent studies suggest, however, that quantal units of caveolae are engaged in continuous rounds of fission and fusion at the cell surface (Pelkmans and Zerial, 2005) . Quantal caveolae behaviour exhibits the same kinetics and characteristics as folate receptor internalization and recycling by potocytosis (Anderson et al, 1992) , which is a caveolae-dependent mechanism for delivering vitamins and ions such as calcium (Isshiki et al, 2002) to the cell interior. Type 2 cavicles can also move rapidly just beneath the membrane. The third type of caveolae behaviour (type 3) is the relatively uncharacterized ability of these domains to form long, thin caveolin-1 (Cav1)-positive tubules that project from the plasma membrane deep into the cell interior (Mundy et al, 2002) . There are no known functions for these tubules, but GPI-anchored prions have been localized to these structures by immunogold electron microscopy (EM) (Peters et al, 2003) . Type 3 caveolae may mediate Cav3-rich tubule formation during skeletal muscle cell development (Parton et al, 1997) . All three types of caveolae behaviours can occur in the same cell.
The three pathways depend on the ability of caveolae to form flask or tubular invaginations and, at least for types 1 and 2, seal off from the extracellular space. Several years ago we initiated a search for molecules that control caveolae internalization and identified PKCa as a regulator of type 2 caveolae internalization (Smart et al, 1995a) . PKCa is highly enriched in caveolae (Smart et al, 1995a) , and deletion of PKCa from cells or displacement from caveolae by AlF 4 or inactivation with inhibitors (Mineo and Anderson, 2001) blocks uptake of folate receptors and flattens the flask-shaped morphology of caveolae. PKCa is probably a natural regulator of caveolae internalization because activation of histamine H1 receptors, which causes the dissociation of PKCa from caveolae, transiently blocks folate internalization (Smart et al, 1995a) . Phosphorylation of an unidentified 90-kDa protein by PKCa has been linked to caveolae internalization. On the basis of these observations, we hypothesized that caveolae contain a protein(s) that recruits PKCa to this domain. Subsequently, we identified SDR (serum deprivation response) protein as a PKCa-binding protein that is enriched in caveolae (Mineo et al, 1998) . PKCa binding to SDR in caveolae is dependent on amino acids 145-250 of SDR, calcium and an intact PKC regulatory domain. Addition of phosphatidylserine (PS) is not required.
SDR (also called PS-p68 and SDPR) is a 412-amino-acid modular protein that contains a leucine zipper (LZ), a PKCbinding site, a PKC phosphorylation site, a PS-binding site and two PEST domains. These structural motifs are also found in PTRF [Pol I and transcription release factor (Jansa et al, 1998) , also called, cavin/cav-p60 (Voldstedlund et al, 2003; Vinten et al, 2005) ] and SRBC [sdr-related gene product that binds to c-kinase (Izumi et al, 1997) ]. On the basis of these motifs, these three proteins form a subset of the STICK (substrates that interact with C-kinase) superfamily of PKCbinding proteins Jaken and Parker, 2000) ). In addition to PKC-binding sites, all STICK proteins contain PS-binding sites and are found at the interface between membranes and the cytoskeleton. They include MARCKS, annexin I and II, desmoykin, vinculin/talin, a-and b-adducin, GAP43 and AKAP79.
Recently, PTRF was reported to be concentrated in adipocyte (Vinten et al, 2005; Aboulaich et al, 2006; Hill et al, 2008; Liu and Pilch, 2008) and smooth muscle caveolae (Voldstedlund et al, 2003) , even though it was originally identified and studied as a transcription release factor (Jansa et al, 1998 (Jansa et al, , 2001 Jansa and Grummt, 1999; Hasegawa et al, 2000) . PTRF has also been implicated in regulating caveolae function (Hill et al, 2008; Liu and Pilch, 2008) .
In contrast to SDPR and PTRF, a relationship between SRBC and caveolae function has not been established. SRBC was initially identified in overlay assays as a PKCdbinding protein (Izumi et al, 1997) . PKCd binds and phosphorylates SRBC in vitro. Similar to SDPR, the mRNA for SRBC is induced in response to serum deprivation as well as during retinoic acid-induced differentiation of P19 cells. SRBC was also identified in a yeast two-hybrid screen as a BRCA1-interacting protein (Xu et al, 2001) . The human SRBC gene maps to 11p15.5-15.4, which is a suppressor region that is mutated in a number of sporadic breast, lung and ovarian cancers. The loss of SRBC in these cancers appears to be caused by DNA methylation and subsequent gene silencing. A follow-up study (Zochbauer-Muller et al, 2005) suggests, however, that DNA methylation is not the only mechanism of SRBC loss in lung cancer cells. SRBC is also downregulated in gastric cancer (Lee et al, 2007) . A naturally occurring fusion protein isolated from colon cancer cells, which consists of the first 184 amino acids of SRBC linked to c-Raf, has celltransforming activity (Tahira et al, 1987) . Interestingly, activation of c-Raf occurs in caveolae (Mineo et al, 1996) and Raf fused to the C-terminal consensus sequence for prenylation is constitutively active in this domain (Mineo et al, 1997) . It is possible, therefore, that the SRBC-Raf fusion protein inappropriately targets c-Raf to caveolae where it is constitutively active.
Here, we report that SRBC is highly localized to caveolae. Targeting of SRBC to caveolae depends on both the LZ domain of SRBC and the expression of Cav1. SRBC is downregulated in response to depletion of Cav1, suggesting that Cav1 stabilizes SRBC. Spinning disc confocal microscopy shows that SRBC is in caveolae, cavicles and caveosomes and traffics with Cav1 to different locations in the cell. In the absence of SRBC, however, intracellular cavicle traffic is markedly impaired.
Results
SRBC was identified in a proteomic screen for proteins enriched in detergent-free caveolae, purified from various cell types (Aboulaich et al, 2004; McMahon et al, 2006) . Alternative splicing of the mRNA for SRBC can potentially produce five different transcripts. The domain organization of these five proteins is shown in Figure 1A . The isoform used in the current study is hSRBCb, which codes for a 261-amino-acid-long protein designated hSRBC (Izumi et al, 1997) . All five isoforms are predicted to be soluble proteins.
We used immunofluorescence and immunogold EM to verify that SRBC is enriched in caveolae. The SRBC mAb we used is directed against the C-terminal end of hSRBCa,b ( Figure 1A , bracket, hSRBCb) and recognizes only human SRBC. This antibody, which detects a single 45-kDa band on immunoblots, colocalizes with Cav1 ( Figure 1B-F) . The scatter plot ( Figure 1D) shows the red and green intensities at each pixel. From these data, we calculated the Pearson's coefficient of correlation (PCC), which measures how well two fluorescent foci coincide (Costes et al, 2004) , to be 0.88 where 1.0 represents perfect colocalization. Another measure of coincidences of the two signals is the colocalization channel ( Figure 1F ), which is a z-axis projection showing voxels that have a statistically significant colocalization. Finally, immunogold labelling ( Figure 1G ) showed a high degree of gold localization to invaginated caveolae as well as endosomal structures that could be either caveosomes or cavicles. Substitution of an irrelevant mAb for a-SRBC IgG did not give labelling (data not shown). Therefore, hSRBC is preferentially associated with caveolae as well as caveolaederived endo-membranes. hSRBC is localized to caveolae in many different human tissue culture cell lines (data not shown).
Tissue distribution of SRBC
We used immunofluorescence to identify tissues that express both hSRBC and Cav1 and determine whether they were both in the same cell type. Samples of human skeletal muscle, liver, stomach, lung, kidney and heart were processed for indirect immunofluorescence (Figure 2 ). Both proteins were expressed in all the tissues we examined, but not in every cell type within an individual tissue. For example, blood vessels expressed both proteins (yellow in the merge) in skeletal muscle tissue, whereas muscle cells per se expressed Cav1 but not SRBC (red in merge). In stomach, connective tissue cells expressed both proteins but neither protein was expressed in epithelium. Importantly, even though many cells expressed Cav1 but not hSRBC (red in the merge images of skeletal, liver, lung and kidney), rarely did we find cells that expressed only SRBC. This raises the possibility that SRBC expression may be linked to Cav1 expression.
LZ is required for targeting to caveolae
We used site-directed mutagenesis to identify regions of SRBC that might be necessary for targeting the protein to caveolae (Figure 3 ). There are at least four regions that could be involved in targeting ( Figure 3A) ; a LZ (aa 22-70), two PEST domains (aa 140-173 and 225-241), a putative PSbinding site (aa 113-124) and a PKC-interacting region (aa 175-194) . We constructed five cDNAs coding for wild type (WT) and mutant hSRBC tagged with HA. Each cDNA was expressed in human fibroblasts and the samples were processed to localize HA (green) and endogenous Cav1 (red). As expected, the WT HA-SRBC colocalized with Cav1 ( Figure 3B , WT coloc) with a PCC of 0.74. Deletion of the LZ shifted hSRBC from caveolae to the cytoplasm and nucleus of the cell ( Figure 3C ), giving a PCC of -0.08, which indicates no specific association with Cav1. By contrast, deletion of the PS-binding site ( Figure 3D ) or the PKC-binding region ( Figure 3E ) or the PEST domain between amino acids 215-241 ( Figure 3F ) had little affect on colocalization (coloc) with caveolin. The PCC for these constructs was 0.63, 0.61 and 0.78, respectively.
To determine the general importance of LZ in targeting this family of proteins to caveolae, we studied SDPR ( Figure 4A ). Similar to hSRBC, SDPR colocalizes with Cav1 ( Figure 4B ; Supplementary Figure 1SA ) and both hSRBC and SDPR colocalize with each other (Supplementary Figure 1SB) . The Figure 1 hSRBC is localized to human fibroblast caveolae. (A) The domain structure of five predicted isoforms of human SRBC. Only hSRBCb was used in this study. The region used to produce the mAb a-SRBC is indicated in brackets. (B-F) Immortalized human fibroblasts were fixed, permeabilized and processed for immunofluorescence to colocalize endogenous hSRBC and Cav1 using an mAb a-hSRBC IgG (B) and pAb a-Cav1 (C). The merged image (E) and the scatter plot (D) show that greater than 88% of a-SRBC and a-Cav1 IgG spots coincide. The colocalization channel (F) is a z-axis projection showing voxels with statistically significant colocalization. Bar ¼ 10 mm. (G) Normal human fibroblasts were processed for immunogold staining with mAb a-SRBC IgG. The majority of the gold particles was associated with invaginated caveolae at the cell surface or cavicles/caveosomes within the cell (arrow). Bar ¼ 0.2 mm.
LZ occupies the same relative position in SDPR (amino acids 52-100), PTRF (amino acids 50-98) and hSRBC ( Figure 4A ). First, we constructed cDNAs that code for amino acids 1-337 (WT), 1-168 and D52-100, all tagged with HA, and expressed them in human fibroblasts. The WT ( Figure 4B , WT) and the 1-168 construct ( Figure 4C, 1-168 ) localized to caveolae. The SDPR construct lacking the LZ domain, by contrast, was found in the cytoplasm and nucleus of the cell but did not colocalize with Cav1 ( Figure 4D , 52-100, PCC ¼ -0.236). Likewise an SDPR with leucines 86, 93 and 100 changed to glutamic acid did not colocalize with Cav1 (Supplementary Figure 1SC) . These results suggest that the LZ has a critical The indicated HA-tagged versions of each construct were transiently expressed in immortalized human fibroblasts. Cells were fixed, permeabilized and processed for colocalization of Cav1 and HA using mAb a-HA and pAb a-Cav1. In (B, D-F), the fluorescence signal for the two antibodies was analysed to map voxels that overlapped between channels (coloc) as well as determine the Pearson's coefficient of correlation of the two images (PCC). Instead of using the colocalization channel for D22-70, we show the merge because of the diffuse distribution of the expressed protein. Bar ¼ 10 mm. the relationship between these two molecules ( Figure 5 ). Immortalized fibroblasts derived from Cav1 À/À mice were transfected with HA-hSRBC alone ( Figure 5A and B) and processed for indirect immunofluorescence detection of HA. HA-hSRBC was diffusely distributed in the cytoplasm ( Figure 5B ) of cells that lack Cav1 ( Figure 5A ). By contrast, when HA-hSRBC was co-transfected with Cav1-GFP, the two proteins colocalized ( Figure 5C and D) and the distribution precisely matched the caveolae staining-pattern usually seen in fibroblasts. Other experiments showed that Cav3-Myc effectively substituted for Cav1 ( Figure 5E and F), whereas hSRBC did not colocalize with Cav2-GFP that appeared to have a Golgi apparatus staining pattern ( Figure  5G and H). A similar result was obtained with SDPR (data not shown). We conclude that all three members of this family depend on either Cav1 or Cav3 to reach the cell surface. A requirement for Cav1 in hSRBC targeting to caveolae suggests the two may physically and functionally interact. To test for a physical interaction, we used an immunoprecipitation protocol to see whether the two proteins would reciprocally co-precipitate from solubilized SV589 human fibroblasts. We solubilized the postnuclear supernatant fraction of these cells using a mixture of Triton X-100 and octylglucoside to ensure the complete solubilization of the caveolae, and then we incubated the soluble material with beads containing either a-Cav1 IgG ( Figure 5I , left panel) or a-SRBC IgG ( Figure 5I , right panel). The beads were washed before the bound proteins were processed for immunoblotting with either a-SRBC IgG ( Figure 5I , IB, left panel) or a-Cav1 IgG ( Figure 5I , IB, right panel). The immunoblots show that a-Cav1 immunoprecipitated hSRBC and a-SRBC immunoprecipitated Cav1. Therefore, under conditions when both proteins are in caveolae the two proteins are directly or indirectly interacting.
In the tissue survey, we carried out to localize Cav1-and hSRBC-expressing cells (Figure 2 ), we rarely found Cav1-negative cells that expressed hSRBC. To explore the possible significance of this observation, we used small interfering RNA (siRNA) to reduce the level of Cav1 in fibroblasts ( Figure 5J ). When we depleted fibroblast Cav1 (lane 1), the amount of hSRBC in the cell markedly declined. A control siRNA did not affect the level of either hSRBC or Cav1 (lanes 2 and 4). By contrast, reducing hSRBC levels did not affect the amount of detectable Cav1 (lane 3). Therefore, the presence of hSRBC appears to be linked to the presence of Cav1, which may explain why we rarely found cells in tissues that expressed hSRBC alone. If the LZ is important for targeting hSRBC to caveolae, then the interaction of Cav1 with DLZ-SRBC may be impaired. Immortalized human fibroblasts were transfected with a cDNA coding for HA-tagged WT or DLZ-SRBC. The cells were then processed to immunoprecipitate HA and both the immunoprecipitate and the lysate proteins were separated on polyacrylamide gels ( Figure 6A ). A silver stain of the IP gel shows that the transfected cells express proteins with the molecular weight expected for WT and DLZ-SRBC (DLZ). The identity of these proteins was verified by immunoblotting ( Figure 6B ). We noticed in the silver-stained gel of the immunoprecipitates (A) that the WT lane contained high molecular weight (*) and a low molecular weight band (**) that were not present in the control lanes. Mass spectrometry identified the top protein as EPS15R. We confirmed that EPS15R co-precipitated with hSRBC by immunoblotting a À/À fibroblasts were transiently co-transfected with cDNAs coding for Cav1-GFP (C) and HA-tagged hSRBC (D) for 24 h, fixed and processed to localize GFP (C) and HA (D). (E, F) Mouse Cav1 À/À fibroblasts were transiently co-transfected with cDNAs coding for Myc-Cav3 and HA-tagged hSRBC for 24 h, fixed and processed for immunofluorescence to localize Myc (E) and HA (
F). (G, H) Mouse Cav1
À/À fibroblasts were transiently cotransfected with cDNAs coding for Cav2-GFP and HA-tagged hSRBC for 24 h, fixed and processed for localization of GFP (G) and HA (H). (I) The PNS fraction from immortalized human fibroblasts was solubilized with Triton X-100-octylglucosidase and incubated with beads conjugated with pAb a-rabbit IgG (control) or pAb a-caveolin-1 IgG. The beads were washed stringently before the bound proteins were eluted from the beads, separated by SDS-polyacrylamide gel electrophoresis and processed for immunoblotting using mAb a-hSRBC IgG (left panel). Another sample of PNS was processed in the same way substituting mAb a-SRBC for mAb a-Cav1 IgG and immunoblotting with mAb a-Cav1 IgG (right panel). (J) Immortalized human fibroblasts were incubated in the presence of siRNAs directed against an irrelevant RNA (lanes 2 and 4), Cav1 RNA (lane 1) and hSRBC RNA (lane 3). After 72 h, the postnuclear supernatant fractions were prepared and processed for immunoblotting using pAb a-Cav1 IgG, mAb a-hSRBC IgG or pAb a-cyclophilin-A IgG as a loading control. Bar ¼ 10 mm.
duplicate gel with antibodies directed against SRBC, Cav1 and EPS15R ( Figure 6B , lanes 2 and 3). Cav1 and EPS15R were not present in the immunoprecipitate of DLZ-SRBC. Lysates used for the immunoprecipitation contained similar amounts of the expressed (SRBC and DLZ-SRBC) as well as endogenous (Cav1 and EPS15R) protein (data not shown).
Cav1 and hSRBC traffic together in cells
Live cell imaging of Cav-GFP has shown that Cav1-rich membranes engage in three types of membrane traffic (types 1-3). To see whether hSRBC traffics with all three types of Cav1-rich membranes, we co-expressed in HeLa cells either hSRBC-tdTomato and Cav1-GFP ( Figure 7A -C) or Cav1-tdTomato and hSRBC-GFP ( Figure 7D-F) and recorded the behaviour of the two proteins with a spinning disc confocal microscope using excitation at 488 nm (GFP) and 568 nm (tdTomato) and the appropriate band-pass filters to separate the two fluorescence signals (Supplementary Movies S1-S3). In agreement with our immunofluorescence data, hSRBC highly colocalized with caveolin ( Figure 7A, yellow) , both on the cell surface and on internal vesicles. Live cell imaging detected all three types of caveolin-rich membranes and in each case SRBC was present. Still images of types 1 and 2 caveolae movement are analysed in Figure 7 . Type 1 hSRBC/Cav-positive cavicles moved at B0.8-2.03 mm/s for several micrometres as if travelling along microtubules ( Figure 7B and C, still images; Supplementary Movie S1). Interestingly, cavicles displayed saltatory movement (Supplementary Movie S1). They paused 11-33 s ( Figure 7A , arrowheads) between segments and often changed direction when movement resumed. Type 2 hSRBC/Cav1-positive cavicles were seen travelling (Supplementary Movie S2) beneath the plasma membrane at an average rate of 2.6 mm/s ( Figure 7D -F, arrow and circles). This population of cavicles did not exhibit long pauses nor did they change direction. Type 3 tubular caveolae were also positive for both hSRBC and caveolin (Supplementary Movie S3). These results indicate that hSRBC is intimately associated with caveolae as well as caveolae-derived membranes such as cavicles and caveosomes, and they both remain associated with these membranes as they travel in the cell.
SRBC regulates cavicle traffic
As pointed out earlier, PKCa regulates caveolae internalization (Smart et al, 1994 (Smart et al, , 1995a and SDPR (also called as SDR) is a candidate caveolar protein responsible for recruiting PKCa to this domain (Mineo et al, 1998) . We used quantitative EM to see whether reducing the level of SDPR RNA in fibroblasts affects caveolae invagination (Figure 8 ). Immortalized human fibroblasts ( Figure 8A ) incubated in the presence of an siRNA against SDPR showed a marked reduction in the number of invaginated caveolae (arrows) compared with cells treated with control siRNA. We quantified the effect of SDPR siRNA in six trials, four for HeLa cells and two for immortalized human cells, by counting the number of invaginated caveola ( Figure 8B ). SDPR siRNA effectively reduced the amount of SDPR RNA in the cell in each trial. On average, the SDPR siRNA caused B57% decline in invaginated caveolae in HeLa cells and B37% in the immortal fibroblast. These results, together with reports that PTRF regulates the number of invaginated caveolae (Hill et al, 2008; Liu and Pilch, 2008) , suggest that hSRBC might also have a function in the budding and/or traffic of caveolaerich membranes. Therefore, we set up a fluorescence recovery after photobleaching (FRAP) assay to determine whether hSRBC affects caveolin-GFP traffic.
Previous live cell imaging experiments showed that in CHO cells GFP-positive cavicles in the centrosome region of the cell overlap with recycling endosomes containing transferrin receptors (Mundy et al, 2002) , and that disrupting microtubules with nocodazole prevented cavicle accumulation at this site (Mundy et al, 2002) . These experiments suggest that cavicles are dynamically associated with the centrosomal region of the cell. We developed an FRAP assay that allowed us to measure the effect of SRBC on cavicle movement from peripheral sites to the centrosomal region. We photobleached the interior population of caveolin-GFP without bleaching the periphery (Figure 9B) , and then monitored the reappearance of individual particles (cavicles) in the centrosomal region over a 150-s period. Under these conditions, the repopulating cavicles can come either from caveolae that have budded from the plasma membrane or existing cavicles in a remote focal plane of the cell that was not bleached. Particles within the region of interest were identified in each frame of the recovery sequence ( Figure 9B , square) using the Spots algorithm of Imaris software (Bitplane, Zurich, SW). The data for each cell was normalized to the baseline number of spots in the first frame obtained after bleaching. The values from approximately 10 cells were averaged for each time point and used to generate a particle reappearance curve ( Figure 9C-F) . As a positive control for the ability of this assay to detect the cavicle movement, we used HeLa cells expressing caveolin-GFP that had been grown in the presence or absence ( Figure 9C , blue diamonds) of either nocodazole (yellow triangle) or genistein (red square). Genistein is a tyrosine kinase inhibitor that blocks caveolae endocytosis (Pelkmans et al, 2001 ). At 120 s after bleaching,
Type 1
Type 2 Figure 7 hSRBC and Cav1 traffic together on type 1 and 2 cavicles. A colour composite and individual frames from a time-lapse sequence of HeLa cells co-expressing red SRBC-tdTomato and green Cav1-GFP (see Supplementary Movies S1-S3). (A-C) The path followed by a single hSRBC-tdTomato/caveolin-GFP-positive type 1 cavicle is traced using Adobe Premiere. The trajectory of the cavicle was divided into four segments. At each of the positions indicated by the arrowheads, the cavicle stopped and hovered on average 19 s (33, 11 and 15 s) before moving on in a new direction. The mean velocity of the moving cavicle, averaged over the four segments, was 1.3 mm/s (1.22, 1.17, 0.8 and 2.03 mm/s). Selected frames from the time-lapse sequence, cropped to the area indicated by the white box in (A). (B) hSRBC-tdTomato; (C) caveolin-GFP. (D-F) The path followed by a single caveolin-tdTomato/hSRBC-GFP-positive type 2 cavicle is traced using Adobe Premiere. Unlike type 1 cavicles, these cavicles do not pause for significant times and have a trajectory that follows the contour of the membrane. The average speed was 2.6 mm/s. (E) Caveolin-tdTomato; (F) hSRBC-GFP. In each frame, the cavicle being tracked is circled in white. Bar ¼ 5 mm.
untreated cells had accumulated on average 20 particles in the bleached region. Nocodazole reduced the accumulation to 2.5 particles (seven-fold suppression) and genistein to 10 particles (B2-fold suppression). We conclude that the FRAP assay quantitatively detects cavicle migration to the centrosome and can be used to detect the effect of inhibitors of the process. We next used the FRAP assay to determine whether hSRBC influences cavicle traffic. We used three non-small cell lung cancer cell lines that express Cav1 but not hSRBC (Sunaga et al, 2004) . Immunoblots show that these three lines express very little ( Figure 9A , lane 3) to no hSRBC (lanes 2 and 4) compared with HeLa cells (lane 1). When any one of these cell types is transfected with a cDNA coding for caveolin-GFP, the GFP signal is found at the cell surface as well as in vesicular structures clustered near the centre of the cell ( Figure 9B Figure 9D-F) was co-transfected with caveolin-GFP plus either empty vector (blue squares) or vector containing the cDNA for hSRBC (red squares). Cavicle traffic was then measured using the FRAP method (see Materials and methods). Comparing the three cells, we found that hSRBCexpressing cells exhibited a 2-to 10-fold increase in particle accumulation following photobleaching. This result suggests that hSRBC regulates microtubule-dependent cavicle traffic to the centrosome of these cells.
Discussion
SRBC is the third member of a family of three proteins that have been implicated in regulating caveolae function. Immunofluorescence shows that all of these proteins are selectively concentrated in caveolae, and that an individual caveola can contain more than one member of the family (for example, Supplementary Figure 1S , SDPR and hSRBC). The ability of these proteins to concentrate in caveolae is either directly or indirectly dependent on the expression of Cav1. At least for SDPR and hSRBC, these proteins can associate with both Cav1 and signalling molecules such as PKC. Therefore, SDPR, PTRF and hSRBC appear to have the properties of a caveolin adapter molecule that links signal transduction to the regulation of caveolae function. On the basis of these similar properties, it seems reasonable that the diverse individual names these proteins have acquired over the years be consolidated with the general family name cavin (Vinten et al, 2005) and the individual names of cavin-1 (PTRF), cavin-2 (SDPR) and cavin-3 (SRBC).
Cavin-1 and caveolae assembly
Cavin-1/PTRF was originally identified as a factor that stimulated the release of pre-rRNA and Pol I from templates during Pol I-mediated RNA transcription (Jansa et al, 1998) . Consistent with this function, cavin-1 interacts with the transcription termination factor TTF-1, Pol I, and the 3 0 end of pre-rRNA. Cavin-1 has two putative nuclear localization signals (amino acids 143-157 and 196-210) and, in addition to its transcription termination function, can stimulate gene transcription (Jansa et al, 1998) . Stimulation of transcription has been linked to its RNA releasing activity (Jansa et al, 2001) . Cavin-1 can also suppress the function of the type I collagen transcription factor BFCOLI (Hasegawa et al, 2000) , which raises the possibility that it regulates multiple genes.
In the face of these well-documented activities, it is somewhat surprising that in several cell types most of the detectable cavin-1 is in caveolae (Aboulaich et al, 2004; Vinten et al, 2005; Hill et al, 2008; Liu and Pilch, 2008) . Moreover, two recent studies (Hill et al, 2008; Liu and Pilch, 2008) suggest that cells lacking cavin-1 are defective in caveolae formation. The role of cavin-1 in caveolae assembly has not been determined. It is important to note, however, both studies reported that knocking down cavin-1 in 3T3 L1 cells markedly reduces the level of Cav1 (as much as 75%). Cav1 is thought to be essential for caveolae formation, which raises the possibility that cavin-1 function in part is to control the number and function of surface caveolae by regulating the transcription of the Cav1 gene. Indeed, overexpressing cavin-1 causes a concomitant increase in the amount of Cav1 (Liu and Pilch, 2008) . Even if it turns out that cavin-1 regulates The number of caveolae in each sample was quantified by measuring the number of caveolae per micrometre of cell surface. Either HeLa cells (experiments 1-4) or SV40-transformed human fibroblasts (experiments 5 and 6) were incubated in the presence of siRNA directed against the RNA of SDPR (SDPR siRNA) or a sense siRNA (Ctrl-siRNA) for 48 h and the amount of SDPR RNA was detected by PCR. The number of invaginated caveolae in each trial was then measured directly on printed electron micrographs. Averaging four trials for HeLa cells, we saw an B57% reduction of invaginated caveolae. For human fibroblast, an B37% loss in SDPR siRNAtreated cells was observed. An observer who did not know the identity of the samples carried out the quantification.
the assembly and structure of caveolae directly, there remains the mystery of why a protein with well-established functions in gene regulation is concentrated in caveolae.
Adapter function of cavins
In contrast to cavin-1, there is no direct evidence that either cavin-2/SDPR or cavin-3/SRBC regulates the transcription of Cav1. To the contrary, we found that Cav1 controls the level of cavin-3 in the cell. As these two cavins share with cavin-1 the ability to target caveolae, we focused on identifying a possible adapter function. Adapter proteins regulate the interactions between signalling molecules located in specific cellular compartments. As cavin-2 and 3 are known PKC-binding proteins, a natural place to look for cavin The top panel is the frame immediately before beginning photobleaching, the middle panel is the frame immediately after photobleaching and the bottom panel is the frame corresponding to the last time point on the graphs of particle recovery. The white box shows the region where particles were counted using Imaris Spots to generate the data depicted on the graphs. To compensate for the loss of total intensity due to photobleaching over the time course of the recovery, Adobe Photoshop was used to enhance the image in the bottom panel by smoothing it with a Gaussian filter of 0.5 pixel radius to remove shot noise and then rescaling it so that the intensity of the unbleached rim of the cell was comparable to the intensity in the first two panels. Bar ¼ 10 mm. (C) HeLa cells transfected with Cav1-GFP were either not treated (blue diamonds), incubated in the presence of 1 mM nocodazole (yellow triangles) or 20 mM genistein (red squares) for 1 h at 371C. (D-F) H358, H460 or H1299 cells were co-transfected either with empty vector plus Cav1-GFP (blue diamonds) or with HA-tagged hSRBC and Cav1-GFP (red squares). Cav1-GFP-expressing cells were selected for the FRAP analysis. The region of interest to be photobleached was defined as everything inside the cell excluding the plasma membrane. A single frame was acquired before bleaching with a 488 laser line at full power for up to 25 s. Recovery was recorded for 150 s after photobleaching. For each FRAP time-lapse sequence, a rectangular region at the centrosome was analysed for particle number with time using the Spots module of Imaris (Bitplane). The particle number in the first frame was taken as the baseline. Each time point in Figure 8 is the average particle number from B10 cells. adapter partner(s) is in caveolae. Mutagenesis experiments showed that targeting of cavin-3 to caveolae was dependent on a four heptad repeat, LZ between amino acids 20 and 76. A three heptad LZ in cavin-2 is also critical for targeting to caveolae, which suggests a general function for LZs in targeting cavins to caveolae. Immunoprecipitation showed that one of the cavin-3-interacting molecules in caveolae is Cav1 and that deleting the LZ blocks this interaction. Another protein that co-precipitated with cavin-3 is EPS15R, which was detected previously in a proteomic analysis of caveolae isolated from adipocytes (Aboulaich et al, 2004) . We conclude that cavins are adapter proteins that link PKC to regulatory networks involved in controlling caveolae function. A model protein for understanding how cavin-3 might function is the adapter SLP-65, which is a critical upstream regulator of the B-cell antigen receptor (BCR) (Engelke et al, 2007) . SLP-65-deficient mice are defective in B-cell development and activation, and they exhibit an increase in pre-Bcell leukaemia. Thus, SLP-65 is a tumour suppressor that increases differentiation and suppresses proliferation of pre-B cells. Cavin-3 has also been reported to be a tumour suppressor. It was isolated in a two-hybrid screen with the first 304 amino acids of BRCA1 and found to be inactive or absent in many breast, lung and ovarian cancer cells (Xu et al, 2001 ). The adapter function of SLP-65 depends on the molecule being at the plasma membrane. Similar to cavin-3, targeting to the cell surface depends on an LZ (Kohler et al, 2005) . Sitedirected substitution of glutamate at L18 and I25 in the LZ converts SLP-65 to a cytosolic protein that is no longer active. Adapter function is restored if a myristoylation consensus sequence is introduced at the N terminus of the LZ-defective protein. LZs, therefore, may have a general function in targeting adapters and other signalling machinery to plasma membrane domains such as caveolae.
Cavin-3 regulates traffic and/or budding of caveolae
Although SLP-65 is intimately involved in regulating the mobilization of cellular Ca 2 þ , the exact signalling pathways regulated by cavins are not clear. Lowering the level of cavin-1 (Hill et al, 2008; Liu and Pilch, 2008) or cavin-2 (Figure 8 ) reduces the number of detectable caveolae. The loss of visible caveolae could be due to a block in the conversion of flat caveolae to invaginated caveolae as occurs when cells are depleted of PKCa (Smart et al, 1994) , a block in the recycling of caveolae following endocytosis (Mundy et al, 2002) or a defect in caveolae assembly (Hill et al, 2008; Liu and Pilch, 2008) . To assay for cavin-3-dependent functions, we developed an FRAP assay that measures the ability of Cav1-GFP-positive cavicles to repopulate the centrosomal region of the cell where recycling endosomes reside. Repopulation involves type 1 transport of newly budded caveolae to the centrosome (inhibited by both genistein and nocodazole) as well as the arrival of existing cavicles that have travelled on microtubules from different regions of the cell (inhibited by nocodazole alone). We used three lung cancer cell lines that all lack detectable cavin-3. GFP-positive cavicle recovery after photobleaching in these cells is very slow (Figure 9 ). In each cell type, however, introduction of cavin-3 markedly accelerates the reappearance of cavicles in the centrosome. These experiments suggest that cavin-3 regulates caveolae budding or movement of cavicles along microtubules or both.
These studies suggest that one of the adapter functions of cavin-3, and cavins in general, is to regulate caveolae traffic. Cavin-1 and -2 may regulate caveolae budding, caveolae assembly or both. The assay methods used in these studies cannot distinguish between the two processes. By contrast, Cavin-3 may regulate the migration of cavicles on microtubules. As all three proteins contain PKC-binding motifs and both cavin-2 and -3 have been shown to bind PKCa and PKCd, respectively, most likely a general function of cavins is to compartmentalize PKC kinase activity in Cav1-rich membranes. Importantly, PKC inhibitors such as staurosporine block endocytosis by caveolae (Mineo and Anderson, 2001; Pelkmans et al, 2001 ). It will be important in future studies to identify the PKC substrates in caveolae, the role of each cavin in targeting the PKC to caveolae and how these substrates function.
Cavin-3 modulation of EGFR targeting to caveolae
The PKC adapter function of cavin-3 may be linked to the targeting of EGFR to caveolae. EGFR was the first receptor tyrosine kinase localized to isolated caveolae (Smart et al, 1995b) . Subsequent work (Mineo et al, 1999) determined that under quiescent conditions EGFR is highly enriched (B7-fold) in caveolae but rapidly departs this domain when the cells are exposed to EGF. EGFR migration from caveolae depends on EGF binding plus a functional tyrosine residue in the regulatory region of the cytoplasmic tail. PKC-dependent phosphorylation of serine 654 markedly reduces EGFstimulated migration of EGFR from caveolae. Therefore, one way that cavin-3 may affect localization of EGFR to caveolae is by linking PKCd to the phosphorylation of EGFR.
There is a second way cavin-3 may regulate the concentration of EGFR in caveolae. We found that immunoprecipitates of cavin-3 contain EPS15R, whereas immunoprecipitates of a DLZ cavin-3 do not ( Figure 6 ). Immunoprecipitates of Cav1 also contain EPS15R (Hartung et al, 2006) . EPS15R is a soluble, Ca 2 þ -binding protein related to the EGFR substrate EPS15 that contains multiple EPS15 homology (EH) domains as well as ubiquitin-interacting motifs (UIMs). EH domains have been implicated in regulating endocytosis, vesicle traffic and signal transduction (Carbone et al, 1997) . Recent studies suggest that EPS15R and the related molecules, EPS15 and epsin, have a critical function in retaining ubiquitinated EGFR in caveolae (Sigismund et al, 2005) . Ubiquitinated EGFR is enriched in caveolae, and high levels of EGF in the media increase the level of ubiquitinated EGFR. This modified EGFR tends to be internalized by caveolae. By contrast, Y1045F EGFR, which cannot be ubiquitinated, is preferentially internalized by clathrin-coated pits. Therefore, a direct interaction between cavin-3 and the UIMs of EPS15 or EPS15R or epsin may function to regulate the traffic of EGFR to and from caveolae membranes. This model implies that cavin-3 links ubiquitinated EGFR to caveolae, whereas unmodified EGFR, released from caveolae, moves to other membrane domains such as clathrin-coated pits.
Conclusion
Cavins are the first set of caveolae proteins that appear to have adapter functions analogous to the clathrin adapter complexes identified over 20 years ago. Clathrin adapters were first identified by their ability to promote the assembly of clathrin-coated vesicles in vitro (Keen et al, 1979) .
Subsequently, this set of molecules was implicated in a range of activities including attracting membrane receptors to coated pits for internalization (Pearse, 1988) . A better understanding of the manner in which cavins work undoubtedly will reveal the full functionality of caveolae and other caveolin-positive membranes.
Materials and methods

Materials
Dulbecco's modified Eagle's medium (DMEM), RPMI 1640, glutamine, trypsin-EDTA were from Sigma (St Louis, MO, USA). Penicillin/streptomycin was from Invitrogen (Carlsbad, CA). Cosmic serum (CS) and fetal bovine serum (FBS) were from HyClone (Logan, UT, USA). pAb a-Cav1 IgG was from BD Bioscience (San Jose, CA). The monoclonal antibody against hSRBC, the full-length HA-tagged hSRBC construct and hSRBC-GFP construct were kindly provided by Dr John Minna (UT Southwestern Medical Center at Dallas, Dallas, TX, USA). Dr Linda Margraf, Department of Pediatrics, UT Southwestern Medical Center, provided samples of human tissue. The tdTomato construct was the generous gift of Dr Roger Tsien (UC San Diego, La Jolla, CA).
Buffer list
Buffer A (PBS), 137 mM NaCl, 10 mM phosphate, 2.7 mM KCl, pH 7.4; buffer B (TBS), 137 mM NaCl, 25 mM Tris-HCl, pH 7.5; buffer C, 3% (w/v) paraformaldehyde in Hank's buffered salt solution containing 20 mM HEPES, 100 mM NaCl, pH 7.3; buffer D, buffer B plus 0.5% Tween-20; buffer E (TETN), 25 mM Tris-HCl, pH 7.5, 5 mM EDTA, 1% Triton X-100, 60 mM octylglucoside plus protease and phosphatase inhibitors; buffer F, 25 mM Tris-HCl, pH 7.5, 5 mM EDTA; buffer G (blocking buffer), buffer D plus 5% dry milk; buffer I (antibody dilution buffer), buffer B plus 0.2% Tween-20 and 1% dry milk; and buffer J (washing buffer), buffer B plus 0.2% Tween-20 and 0.2% dry milk.
Cell culture SV589 human fibroblasts were cultured in DMEM supplemented with 10% (vol/vol) CS, 100 U/ml penicillin and 100 mg/ml streptomycin. SV589 human fibroblasts were seeded at 1 Â10 6 cells/ml on day 1 and were routinely used on day 3. Cav1 À/À mouse fibroblasts were isolated from the thymus of Cav1 KO mice. The thymus was sliced into very small pieces and cultured in DMEM supplemented with 10% (vol/vol) FBS, 100 U/ml penicillin and 10 mg/ml streptomycin for 1 day. Non-adherent cells were removed from the culture with several washes of medium and then adherent fibroblasts were cultured over 25 passages. These cells were further subcloned to give a clonal population of Cav1 þ / þ and Cav1 À/À immortalized fibroblasts. HeLa cells and non-small cell lung carcinoma cells (H1299, H460 and H358) were obtained from the Hamon Center Collection (UT Southwestern Medical Center at Dallas) and cultured in high glucose DMEM supplemented with 10% (vol/vol) CS, 100 U/ml penicillin and 100 mg/ml streptomycin.
Preparation and transfection of synthetic siRNA
The siRNA sequences against CAV1 (CAV1-1 siRNA) were 5 0 -CAUCUACAAGCCCAACAATT-3 0 (sense) and 5 0 -GUUGUUGGGCUU-GUAGAUGTT-3 0 (antisense), against hSRBC (SRBC siRNA) were 5 0 -GAAGCUCUGCUCCAAAUGG-3 0 (sense) and 5 0 -CCAUUUGGAG CAGAGCUUC-3 0 (antisense) and against SDPR (SDPR siRNA) were 5 0 -CCAUUUCAAAGUGCUCAUCTT-3 0 (sense) and 5 0 -GAUGAGCA CUUUGAAAUGGTT-3 0 (antisense). The siRNA target sequences were tested in a BLAST search of GenBank (National Center for Biotechnology Information database) to ensure that only the corresponding gene is the target. RNA oligonucleotides to hSRBC were obtained from the core facility of the University of Texas Southwestern Medical Center and RNA oligonucleotides to Cav1 and SDPR were obtained from Dharmacon RNA Technologies (Lafayette, CO, USA). siRNAs were transfected into cells using oligofectamine transfection reagent (Invitrogen) with a ratio of 6 ml oligofectamine to 400 pmol siRNA. Cells were grown and harvested after 3 days before further analysis. RT-PCR and PCR reaction was performed with Superscript First Strand Synthesis (Invitrogen) with 1 Â buffer containing 50 mM MgCl 2 , 2.5% DMSO, 10 mM dNTP and 10 mM primers in a 40-ml reaction. The primers for detecting hSRBC RNA are (forward) 5 0 -GGAGCAGAGCGGTCAGGGATC-3 0 , and (reverse) 5 0 -GGACCGTTTGAGGTCACTGAC-3 0 , whereas for SDPR RNA the forward strand was 5 0 -GTGCAAGAGTTTGTTCTTCAGCCC-3 0 and the reverse was 5 0 -GCCTGAAGAAAGTGGATAGCCTCA-3 0 . The cycle conditions for hSRBC-and SDPR-specific primers were 75-651C touchdown (one cycle at 951C (5 min); 10 touchdown cycles at 941C (30 s), 751C (30 s) with a decrease of 11C each cycle, and at 721C for 30 s; followed by 30 cycles of 941C (30 s), 651C (30 s) and 721C (30 s), with a final extension at 721C for 7 min.
Construction of normal and mutant hSRBC cDNA
A series of deletion mutations in hSRBC were generated by PCR from the original cDNA clone of hSRBC using a site-directed mutagenesis kit (Roche, Indianapolis, IN, USA). The resulting hSRBC mutant constructs were confirmed by sequencing. For transient expression of hSRBC mutants, SV589 cells were transiently transfected using Fugene 6 HD reagent (Roche) according to the manufacturer's protocol. The LZ mutant of hSRBC contains a deletion of amino acids 22-70, the putative PS-binding mutant contains a deletion of amino acids 113-124, the PKC-binding mutant contains deletion of amino acids 172-194 and the PEST mutant contains deletion of amino acids 199-247. Cav À/À mouse embryo fibroblasts were transfected by electroporation using the Amaxa MEF kit 1 according to the manufacturer's instructions (Amaxa, Gaithersburg, MD; cat. no. VPD-1004) or by microinjecting cDNAs into the nucleus of individual cells.
Immunofluorescence and immunogold EM
Cells plated onto coverslips in 12-well plates were fixed either with buffer A containing 4% paraformaldehyde at room temperature or with methanol at À201C. Fixed cells were permeabilized with buffer A containing 0.2% Triton X-100. Nonspecific binding sites were blocked by incubating coverslips for 30 min in buffer A containing 0.5% BSA (Sigma). Fixed cells were incubated with primary antibodies diluted in buffer A containing 0.5% BSA for 1 h, washed with buffer A containing 0.5% BSA several times and then incubated with the appropriate secondary antibodies conjugated to the specified Alexa dyes (Invitrogen) for 1 h before mounting with Aqua Poly Mount (Polysciences Inc., Warrington, PA). Through-focus series of 10-12 optical slices were collected and deconvolved using a Deltavision RT deconvolution microscope (Applied Precision, Issaquah, WA, USA). Pearson coefficients were determined using the colocalization algorithm of either the Deltavision RT software or Imaris. Images presented in Figures 1, 3-5 and 7 were sharpened and contrast enhanced using Adobe Photoshop.
Normal human tissues were fixed in 10% formalin buffered in phosphate and then embedded in paraffin. Paraffin sections (5 mm thick) were de-waxed in three changes of xylene (10 min each) and rehydrated into buffer A. The sections were washed with buffer A containing 50 mM NH 4 Cl for 30 min and blocked by incubation for 30 min with buffer B containing 10% (v/v) normal goat serum and 1% (w/v) bovine serum albumin. For double immunofluorescence staining, mAb hSRBC IgG (1:200 dilution) with rabbit anti-Cav1 (10 mg/ml) or non-immune mouse IgG (1:200 dilution) or nonimmune rabbit IgG (10 mg/ml) was applied to the coverslips overnight at 41C. The sections were washed three times in buffer B containing 0.1% BSA. Bound primary antibody was detected by incubation for 2 h with Alexa-Fluor 488-conjugated goat anti-rabbit IgG (10 mg/ml; Molecular Probes, Eugene, OR) and Alexa-Fluor 568-conjugated goat anti-mouse IgG (10 mg/ml). The tissues slides were washed three times in buffer B containing 0.1% BSA, rinsed with water and mounted under a coverslip with Fluorescence Mounting Medium (Dako, Carpinteria, CA). Images were taken using Leica TCS SP confocal microscope.
For EM analysis, cells were processed for indirect immunogold detection of hSRBC (Li et al, 2001) . Human fibroblasts were cultured in 100-mm dishes to 95% confluence and immersion-fixed in freshly prepared buffer C for 60 min. The cells were enclosed in 2% (w/v) agar and then infused in 2 M sucrose containing 15% (w/v) polyvinylpyrrolidone (10 kDa). Frozen ultrathin sections were prepared using a Leica Ultracut UCT ultramicrotome equipped with a Leica EMFCS cryochamber. The sections were lifted onto nickel grids with infused solution and stored overnight on gelatin at 41C. Before immunolabelling, the gelatin was liquefied at 371C, and the nickel grids were removed. We washed the sections by floating them on droplets of buffer A. For immunogold localization, the grids with the attached thin sections were conditioned on droplets of buffer A containing 1% (w/v) bovine serum albumin, 0.01% (v/v) Triton X-100 and 0.01% (v/v) Tween-20 for 10 min at room temperature. The grids were incubated for 2 h in the presence of mouse monoclonal anti-SRBC IgG (1:50 dilution) in buffer A with 0.5% BSA. The sections were rinsed on droplets of buffer A and then incubated with 5-nm gold-labelled goat anti-mouse IgG (diluted 1:40; Amersham Biosciences UK Limited, Little Chalfont, Buckinghamshire, UK) in buffer A with 0.5% BSA. Finally, the grids with the attached thin sections were rinsed in buffer A, fixed with buffer A containing 2% (v/v) glutaraldehyde for 10 min and positive contrast stained (Takizawa and Robinson, 2003) . Electron micrographs were taken using a JEOL 1200 electron microscope operating at 80 kV.
Electrophoresis and immunoblotting
Each sample was concentrated by TCA precipitation and washed in acetone. Pellets were suspended in Laemmli sample buffer (Laemmli, 1970) , heated at 951C for 5 min and loaded onto 10% SDS-PAGE. The separated proteins were transferred to PVDF membranes (Millipore, Billerica, MA, USA). The membrane was blocked in buffer G for 1 h at room temperature. Primary antibodies were diluted in buffer I and incubated with the membrane for 1 h at room temperature. The membrane was washed three times for 3 min each in buffer J and incubated with the appropriate HRPlabelled anti-IgG in buffer I for 1 h at room temperature. The membrane was then washed, and the bands were visualized by enhanced chemiluminescence reagent (Amersham Biosciences UK).
Immunoprecipitation SV589 human fibroblasts were lysed in buffer E plus 150 NaCl for 30 min at 41C. Lysates were incubated overnight at 41C with the indicated antibody and protein A-Sepharose CL-4B beads (500 mg of protein; 5 mg of IgG; 50 ml of beads). Immunoprecipitates were washed twice with buffer E containing an additional 250 mM NaCl, twice with buffer E plus 150 mM NaCl and twice in buffer F. Proteins were eluted from beads with SDS sample buffer, separated by SDS-PAGE, transferred to PVDF membrane and blotted with the indicated antibodies.
Spinning disc confocal microscopy hSRBC-tdTomato was made by inserting hSRBC into the HindIII/ EcoRI cut site and tdTomato into the XhoI/XbaI cut site of pCDNA3.1/V5-His A mammalian expression vector (Invitrogen). Cav1-GFP was constructed as described previously (Mundy et al, 2002) . The cells were plated in glass-bottomed 35-mm dishes (MatTek Corporation, Ashland, MA) and co-transfected with Cav1-GFP and hSRBC-tdTomato using Fugene (Roche) according to the manufacturer's instructions. At 24-48 h after transfection, fluorescence time-lapse recordings were made at Â 63 with a spinning disc confocal microscope (Ultraview ERS; Perkin Elmer, Waltham, MA) using 488-and 568-nm laser lines for excitation and the appropriate band-pass filters to separate the two fluorescence signals. The samples were maintained at 371C using a stage-mounted heater and an objective heater (Carl Zeiss Microimaging, Thornwood, NY).
FRAP analysis
For FRAP, the cells were plated in glass-bottomed 35-mm dishes (MatTek Corporation). HeLa cells transfected with Cav1-GFP were used for the drug treatment experiments. To examine the role of hSRBC in caveolae trafficking, non-small cell lung carcinoma cells (H358, H460 and H1299), which express Cav1 but not hSRBC as determined by western blotting (Sunaga et al, 2004; Xu et al, 2001) , were obtained from the Hamon Center Collection. The cells were transfected with empty vector and Cav1-GFP cDNA or with WT-SRBC and Cav1-GFP using Fugene (Roche) according to the manufacturer's instructions for 18 h, after which the medium was changed to CO 2 -independent medium (cat. no. 18045088; Gibco BRL, Grand Island, NY, USA). Imaging was performed using a Zeiss LSM510 confocal microscope (Carl Zeiss Microimaging). Cells were maintained at 371C using a stage-mounted heating unit. HeLa cells transfected with Cav1-GFP were left untreated as a control or were treated with 1 mM nocodazole (Sigma) or 20 mM genistein (Calbiochem, San Diego, CA, USA) for 1 h at 371C. For FRAP, a region of interest containing everything within the boundary of the cell was defined in a single focal plane and fluorescence within the region was bleached with a 488 nm laser line at full power for 30 iterations (about 25 s). Z-stacks taken before and after bleaching showed that this protocol typically results in bleaching of fluorescence throughout the thickness of the cell. Recovery was recorded for an additional 150 s after photobleaching at time intervals of 1 s. For the analysis of recovery, a region of interest near the centrosome was defined and the number of GFP-positive particles in this region was analysed for each frame of the time-lapse sequence using the automated spot detection algorithm of Imaris software, setting the minimum particle diameter to 0.2 mm and choosing an intensity threshold (typically o20) that minimized the number of particles in the first frame after photobleaching. The particle number in the first frame after photobleaching was taken as the baseline. Data from 10 cells were combined and the average particle number above baseline in each frame was plotted against frame number.
Mass spectrometry
For proteins that co-precipitated with the WT hSRBC construct and not with an hSRBC construct lacking the LZ (amino acids 22-70), the corresponding silver-stained bands were excised from the gel slab. Each protein band was cut into 1-mm pieces, and destained in 25 mM NH 4 HCO 3 , 50% methanol, 50% water three times for 10 min. They were washed with equal volumes of 10% acetic acid, 50% methanol, 40% water three times for 1 h, and swollen in water twice for 20 min. The gel pieces were dehydrated with ACN and dried in SpeedVac (Thermo Savant, Holbrook, NY, USA). The gel pieces were again rehydrated with modified porcine trypsin (Promega, Madison, WI, USA) at a concentration of 10 ng/ml in 50 mM NH 4 HCO 3 and then subjected to trypsin proteolytic digestion at 371C overnight. Tryptic peptides were sequentially extracted with an equal volume mixture of 50% ACN, 45% water and 5% TFA followed by an equal volume mixture of 75% ACN, 24.9% water and 0.1% TFA. The peptide extracts were combined and dried in SpeedVac. The peptide samples were cleaned with ZipTip C18 (Millipore) prior to HPLC-MS/MS analysis. HPLC-MS/MS analysis and protein sequence identification were performed as described previously (McMahon et al, 2006) .
Supplementary data
Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).
